StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued to investors on Saturday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
Ampio Pharmaceuticals stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47. The firm has a market capitalization of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.71. The company has a 50 day moving average price of $0.02 and a 200 day moving average price of $0.02.
About Ampio Pharmaceuticals
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- Insider Buying Explained: What Investors Need to Know
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Short a Stock in 5 Easy Steps
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
